These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23649168)

  • 1. CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.
    Al-haidari AA; Syk I; Jirström K; Thorlacius H
    Int J Colorectal Dis; 2013 Nov; 28(11):1479-87. PubMed ID: 23649168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
    Al-Haidari AA; Syk I; Thorlacius H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.
    Al-Haidari AA; Syk I; Thorlacius H
    Oncotarget; 2017 Feb; 8(9):14887-14896. PubMed ID: 28146427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and function of chemokine TARC/CCR4 at fetal-maternal interface in first trimester].
    Li CM; Hou L; Zhang H; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):421-6. PubMed ID: 24103120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.
    Yang Y; Li L; He H; Shi M; He L; Liang S; Qi J; Chen W
    Exp Cell Res; 2022 Feb; 411(2):113004. PubMed ID: 34990618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
    Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
    Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL17/thymus and activation-regulated chemokine induces calcitonin gene-related peptide in human airway epithelial cells through CCR4.
    Bonner K; Pease JE; Corrigan CJ; Clark P; Kay AB
    J Allergy Clin Immunol; 2013 Oct; 132(4):942-50.e1-3. PubMed ID: 23731651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
    Sato T; Iwase M; Miyama M; Komai M; Ohshima E; Asai A; Yano H; Miki I
    Pharmacology; 2013; 91(5-6):305-13. PubMed ID: 23751403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
    Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
    PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
    Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
    Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
    Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3
    Maeda S; Nakazawa M; Uchida M; Yoshitake R; Nakagawa T; Nishimura R; Miyamoto R; Bonkobara M; Yonezawa T; Momoi Y
    Vet Pathol; 2020 Jul; 57(4):497-506. PubMed ID: 32347186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
    Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
    Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
    Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
    Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential roles of the CCL17-CCR4 axis in immunopathogenesis of oral lichen planus.
    Shan J; Shen C; Fang J; Li S; Fan Y
    J Oral Pathol Med; 2020 Apr; 49(4):328-334. PubMed ID: 31322295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK/STAT3 activation through CCL17/CCR4 axis-mediated type 2 cytokine-involved signaling pathways in Th2 cells regulates cutaneous drug reactions.
    Tang JT; Gao KC; Zhang Y; Zhou XY; Yang LH; Kuang YQ; Li YY
    Int Immunopharmacol; 2024 Mar; 130():111712. PubMed ID: 38377858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
    Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
    Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR4 is a determinant of melanoma brain metastasis.
    Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
    Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.